ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Bioscience Animal Health PCL's annualized return on capital (ROC %) for the quarter that ended in Mar. 2026 was 15.35%.
As of today (2026-07-13), Bioscience Animal Health PCL's WACC % is 9.06%. Bioscience Animal Health PCL's ROC % is 7.50% (calculated using TTM income statement data).
Bioscience Animal Health PCL earns returns that do not match up to its cost of capital. It will destroy value as it grows.
Bioscience Animal Health PCL (BKK:BIS) ROC % Explanation
ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.
There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.
Why is ROC % important?
Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.
As of today, Bioscience Animal Health PCL's WACC % is 9.06%. Bioscience Animal Health PCL's ROC % is 7.50% (calculated using TTM income statement data).
Bioscience Animal Health PCL earns returns that do not match up to its cost of capital. It will destroy value as it grows.
Be Aware
Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Bioscience Animal Health PCL ROC % Related Terms
Bioscience Animal Health PCL ROC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note:
The Operating Income data used here is four times the quarterly (Mar. 2026) data.
The tax rate is limited to between 0% and 100%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioscience Animal Health PCL (BKK:BIS) has a ROC % of 15.35% as of Mar. 2026. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Bioscience Animal Health PCL and its competitors.
Is Bioscience Animal Health PCL's ROC % too high?
Bioscience Animal Health PCL's current ROC % is 15.35%. The Consumer Packaged Goods industry median ROC % is 5.16. Bioscience Animal Health PCL's value of 15.35% is 197.5% above this industry median. Overall, Bioscience Animal Health PCL has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bioscience Animal Health PCL's ROC % compare to KHC and GIS?
Bioscience Animal Health PCL's ROC % of 15.35% can be compared against companies in the Consumer Packaged Goods industry. The industry median ROC % is 5.16. Bioscience Animal Health PCL's value of 15.35% is 197.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Consumer Packaged Goods company?
The median ROC % among Consumer Packaged Goods companies is 5.16, based on 1,949 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bioscience Animal Health PCL's current ROC % of 15.35% is 197.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Bioscience Animal Health PCL and its competitors. For the Consumer Packaged Goods industry, the median ROC % is 5.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioscience Animal Health PCL's current ROC % is 15.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioscience Animal Health PCL stock overvalued right now?
Based on GuruFocus' analysis, Bioscience Animal Health PCL (BKK:BIS) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿2.87, compared to a current price of ฿2.06 — trading 28.2% below its estimated fair value. The current ROC % is 15.35% and 197.5% above the Consumer Packaged Goods industry median of 5.16. Bioscience Animal Health PCL's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Bioscience Animal Health PCL (BKK:BIS), the current ROC % is 15.35% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bioscience Animal Health PCL (BKK:BIS) Overvalued in 2026?
Based on GuruFocus' analysis, Bioscience Animal Health PCL stock appears to be undervalued.
The current stock price of ฿2.06 is trading 28.2% below its estimated GF Value™ of ฿2.87.
GuruFocus considers Bioscience Animal Health PCL to be Modestly Undervalued.
Key valuation signals for BKK:BIS:
ROC %: 15.35%
GF Value™: ฿2.87 vs. price of ฿2.06 (28.2% below fair value)
Industry Position: 197.5% above the Consumer Packaged Goods median
No single metric tells the full story. See the BKK:BIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bioscience Animal Health PCL along with its subsidiaries is engaged in the manufacturing, import and distribution of pharmaceutical supplies, medical devices, equipment and products for livestock and companion animals (pets). Geographically, the company generates revenue from Thailand, and also has presence in other countries.
81GF Score
Get the complete analysis for BKK:BIS
ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:BIS has been successfully added to your 
